Kazakhstan Manager
Yi Pressimone
The Program Manager is the key position for this Activity and will manage and lead the technical component of the Activity. The Program Manager will ensure the effective technical component implementation and work closely with the Chief of Party to provide managerial and technical oversight for the component.
Swixx BioPharma began operations in December 2014 and is registered in Baar, Switzerland. The company has 100%-owned affiliates in Albania, Belarus, Bosnia & Herzegovina, Bulgaria, Croatia, the Czech Republic, Estonia, Greece, Hungary, Kazakhstan, Latvia, Lithuania, North Macedonia, Montenegro, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, UAE and Uzbekistan. As of June 2024, Swixx operates in Latin America through Biopas, a Swixx BioPharma company, addressing the needs of patients in almost 20 countries in LatAm.
Both Swixx BioPharma senior management and owners come from a heritage of unique success in specialty pharmaceuticals. Dynamic business development activities and the ability to enter new markets quickly helped Swixx to achieve one of the leading positions in CEE and beyond.
Our vision is to become the partner of choice for biopharma companies when they choose an indirect route to market, thereby improving patient outcomes. By providing best-in-class pharma services, building on our deep industry knowledge and fostering professional and collaborative relationships with our partners, patients representatives and the entire healthcare community, we believe we can create a healthier future for all.
Our mission is to work closely with our partners and broad healthcare communities to unlock access to innovative treatments for patients in need. Our ultimate goal is to make a meaningful and lasting impact on the health of individuals and communities in the countries where we operate.
Member of Management and Head Private Equity at HBM Partners. Over twenty years of experience in private and public equity investment management and research. Former experience includes senior analyst at Lombard Odier and scientist at the Swiss Federal Institute of Technology. In addition to Swixx, Board member of Sphingotec, Numab, Farmalatam and Board Observer Tata 1mg.
Founder of Laboratories Biopas with 35+ years of experience in the pharma industry, from Schering-Plough Pharmaceuticals, Grupo Farma and Hoechst Marion Roussel (HMR), now Sanofi, in Europe, Intercontinental and Latin America regions.
Previously BMS Vice-President and Ass. General Counsel, Head of Intercontinental R/C Law Department responsible for 65 markets including CEE, Middle East, Africa and India; China, Pacific Rim, Brazil, Latin America; Before that, BMS Vice-President and Ass. General Counsel, Head of R/C Law department Europe supporting all European countries and Distributor Markets of Europe.
Joins from May 2023 from Bristol Myers Squibb, from the position of Transition Lead CEE and Interim General Manager Australia. Previous experience includes almost 23 years at BMS as GM Russia for 5 years, as well as various senior commercial roles, and 6 years in Novartis.
Formerly Country Manager of Bristol-Myers Squibb, responsible for Austria, before that for Czech Republic and Hungary. Prior to this held various commercial and finance positions at BMS in different Central European countries
Previously Head of Regulatory Department for non-EU Balkan countries at PharmaSwiss, prior to that Regulatory Affairs Director (2009-2013) and Regulatory Affairs Manager (2007-2009) at PharmaSwiss Serbia and Regulatory Affairs Officer at Schering Plough Serbia.
More than 20 years experience in pharma industry, holding a series of roles with increasing responsibility in hospital devices, medical nutrition and specialty care in Abbott & AbbVie for Greece and Cyprus. Most recently served as Business Unit Director Immunology.
In Pharma industry as of 2002. Formerly Country manager for Croatia and Slovenia in Celgene. Prior to that held various positions in Alpe-Adria region such as Business unit head, Market access head, Marketing and Sales management in rare diseases, hospital, primary care and OTC area.
Eight years of pharma sales & marketing experience as BUD for Pfizer and Krka Hungary. Prior to that, 16 years in different finance/consulting roles including Finance Director for Pfizer Hungary and GM/FD for Tele2.
Before joining Swixx Biopharma served as GM A&D Pharma Marketing and Sales Bulgaria for the last 7 years. Prior to that, BUH Hospital and Specialized products within A&D Pharma Bulgaria. Previously held various positions in BMS (BUH Oncology/Hospital products & Medical Director Bulgaria & Romania) since 1996.
Formerly Country Manager in Boston Scientific. Over 15 years of experience in the pharmaceutical and medical devices industry, including various positions in innovative companies (Takeda, Novartis Amgen, MSD and Schering Plough).
Formerly Country Manager Alexion Poland, Greece, Cyprus, Israel, Romania and Bulgaria. Prior to that held position of Area General Manager for Poland, Baltic Countries and Russia in AOP Orphan Pharmaceuticals.
Formerly Public Affairs and Market Access Head Albania and Kosovo in Sanofi and Country Chair Albania. Prior experience includes the position of General Manager Albania and various roles in Sales and Marketing in Sanofi.
23+ experience in pharma at executive positions, former General Manager of Ipsen in Russia and CIS (9Y), Pierre Fabre General manager Russia (7Y), Sanofi Trade and Revenue head Russia and EurAsia (5Y) and before joining Swixx Biopharma was Commercial VP for Greece, Russia and Turkey in Italpharmaco.
Formerly Trade & Revenue Director for Central Asia, Caucasus and Belarus in Sanofi. Previous roles include various Supply Chain and Commercial functions with progressively increasing responsibilities.
20+ experience in Pharma, formerly Global Go-To-Market Transformation Operations Lead in Sanofi. Previous positions include General Manager GenMed Business Unit Southeast and Central Europe, Sanofi, and other local, regional and global positions in Sales, Marketing, Market Access and Organizational effectiveness in Sanofi, Eli Lilly and Pliva/Teva.
Formerly Head of Immunology Central and South Europe, Sanofi. Experience includes various positions in Marketing, Medical affairs, Business Unit Director position with gradual expansion of geographic scope in Sanofi and Schering Plough.
Formerly Cardiovascular Medical Lead for Southeast and Central Europe Sanofi. Previously held various regional and country Medical and Commercial roles in Sanofi and Boehringer Ingelheim. Served as General manager of Bulgarian enterprise manufacturing producing vaccines and biological products.
20+ years of experience in pharma and biotech. Formerly Value, Access and Policy Senior Manager in Amgen. Previously held various Commercial and Marketing positions in PharmaSwixx, including Business Unit Head and Sales and Marketing Director, with increasing P&L responsibilities.
Formerly Commercial Head, Southeast & Central Europe. More than 20 years of experience from Sanofi, including various positions in both Marketing and Sales. Proven results in leading and developing teams. Increased responsibility in terms of geography, organization size and the turnover over the time.
Previous position was General Manager Sanofi Pasteur Czech Republic and Slovakia. Held various roles in Commercial, Business Development and Business support with experience leading and developing people and almost a decade long experience in Country P&L Management.
Formerly CEE Commercial Lead in Kyowa Kirin. Previously held various leadership roles with increasing responsibility and geographic scope in global pharma companies e.g. Astellas, Takeda, Shire, Baxter and Novartis.
Formerly Business Excellence Manager for Southeast Central Europe in Sanofi. Held various positions in Sales, Commercial and Trade management, with preference for Business Operations, Sales Force excellence and product launches.
Joins Swixx BioPharma from Ipsen where he held positions of Finance Director Germany/Austria/Switzerland, Head of Finance of International Clusters/China, and Head of Finance Europe. Prior to Ipsen, Michal worked for 14 years in BMS on various positions with increasing geographical responsibilities.
Public relations and communications professional with over 25 years of experience working with multinational companies from pharmaceutical and FMCG industries, public sector and sports industry, including Roche and GSK.
c80f0f1006